An oxygen supply unit for use with a blood oxygenator comprises an oxygen concentrator and a carbon dioxide scrubber. In an on-line operational mode, oxygen-rich gas from the oxygen concentrator is predominantly supplied to the blood oxygenator with a reduced flow of recycled gas from the concentrator. In an off-line operational mode where the oxygen supply unit is being powered by battery only, a larger flow of recycled gas from the blood oxygenator is passed through the carbon dioxide scrubber and combined with a lesser amount of oxygen-rich gas from the oxygen concentrator. The oxygen supply unit may be used in combination with a blood pump and oxygenator to provide ambulatory blood oxygenation to patients with compromised lung function.

A technology that provides various modular biomimetic microfluidic modules emulating varieties of microvasculature in body. These microfluidic-base capillaries and lymphatic Technology modules are constructed as multilayered-microfluidic microchannels of various shapes, and aspect ratios using diverse biocompatible microfluidic polymers. Then, various semipermeable membranes are sandwiched in between these multilayered microfluidic microchannels. These membranes have different chemical, physical characteristics and MWCO values. Consequently, this design will produce much smaller dimension channels similar to human vasculature to achieve biomimetic properties like of human organs and tissues. By interchanging microfluidic-layers or the membranes various diverse modules are designed that act as building blocks for constructing various medical devices, various forms of dialysis devices including albumin and lipid dialysis, water purification, bioreactors, bio-artificial organ support systems. Connecting various modules in diverse combinations, permutations, in parallel and/or in series to ultimately design many unrelated medical devices such as dialysis, bioreactors and organ support devices.

Described herein are systems, devices, and methods for an extracorporeal, artificial, placenta. In some embodiments, an artificial placenta and amniotic bed system may comprise a control unit, a gas delivery unit, a gas exchange unit or membrane oxygenator, a fluids delivery unit, an amniotic fluid bed, and a human machine interface. In some embodiments, the artificial placenta and amniotic bed systems, devices, and methods described herein may improve survival rates and minimize long-term disabilities in preterm, gestational-age, newborns. In some embodiments, the extracorporeal systems, devices, and methods comprise an artificial network through which oxygen and nutrient-rich blood may flow into a fetus (residing in an amniotic fluid bed), while carbon dioxide and wastes may be removed, thus re-establishing a form of intrauterine placental circulation.

A blood loop system for controlling blood oxygen saturation includes a conduit loop, a pump, a flow cell, a matter source, an aeration chamber, a collection chamber and an oxygen probe. The pump is coupled to the conduit loop and positioned to circulate blood through the conduit loop. The flow cell is positioned to measure a characteristic of the blood circulated through the conduit loop. The matter source includes a gas. The aeration chamber is coupled to the conduit loop and is in fluid communication with the matter source to enable the gas to combine with the blood. The collection chamber is in fluid communication with the aeration chamber and is positioned to receive the blood. The oxygen probe is positioned to measure an amount of oxygen in the blood.

Fluid reactors include a sealed housing enclosing a reactor core that includes at least one substrate-free multichannel reactor core element. Each reactor core element is made from a non-substrate mounted, open pore cellular network material having an asymmetric, tortuous, bi-continuous two-phase material structure and contains multiple perforating fluid channels. Multiple reactor core elements can be serially and/or parallelly piped in a sealed manner to form a reactor core for a fluid reactor with a higher production capacity.

According to some embodiments, a system may treat blood outside the body of a patient. The system may include one or more pumps configured to pump blood in a fluid flow path at a collective rate over 4 liters per minute. The system may include one or more heat exchangers operable to heat at least a portion of the blood to a temperature of at least 42 degrees Celsius and to allow the blood to cool one or more degrees following heating. The system may include one or more albumin dialysis modules configured to perform albumin dialysis on at least a portion of the blood at least after the one or more heat exchangers allow the blood to cool one or more degrees.

An extracorporeal blood pump assembly includes a blood pump and an extracorporeal membrane oxygenator (ECMO). The blood pump includes a pump housing, a rotor, and a flow converter positioned downstream from the rotor to convert non-axial flow from the rotor to axial flow. The pump housing defines an inlet and an outlet. The ECMO includes a membrane housing and an oxygenator membrane disposed within the membrane housing. The membrane housing is removably connected to the pump housing at one of the pump housing inlet and the pump housing outlet.

Microfluidic gas exchange devices may include one or more exchange modules (100), wherein each exchange module includes: a first layer comprising: one or more primary inlets (108); a first capillary network connected to the one or more primary inlets, wherein the first capillary network extends radially outward from at least one of the one or more primary inlets, and wherein the first capillary network includes one or more injection branches (104) and a series of microchannels (106); and one or more primary outlets connected to the first capillary network; and a second layer that includes a semipermeable membrane.

The invention concerns a control or regulating device with a control or regulating unit, which both controls or regulates a volumetric blood flow flowing through a blood pump as well as a volumetric flow of a gas able to flow through a gas exchange unit.

A blood gas management device comprises a blood passage having a gas-blood interface with a plurality of gas passages, and is arranged to direct a flow of supply gas from the gas inlets through the gas passages to the gas outlets, and to allow a flow of blood in a blood flow path through the blood passage to thereby permit an exchange of blood gas with the supply gas via the interface. The blood gas management device comprises a supply gas distribution arrangement allowing the supply gas to be provided from different directions relative to the blood flow path. This provides an improved gas-transfer gradient at different locations along the gas passage.